TraceLink Partners With Excellis to Provide Local Implementation Services for its Russia Compliance Solution Through One Global Compliance Platform Read more
Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors Read more
Amgen And Allergan’s MVASI (bevacizumab-awwb) And KANJINTI (trastuzumab-anns) Now Available In The United States Read more
FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections Read more
Epistem licence Hubrecht Organoid Technology to expand pre-clinical toxicology service portfolio Read more
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101) Read more
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury Read more